Orchestra BioMed Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.54 | -$0.19 | -$0.40 |
| Q2 2024 | 1 | -$0.53 | -$0.19 | -$0.39 |
| Q3 2024 | 1 | -$0.59 | -$0.21 | -$0.43 |
| Q4 2024 | 4 | -$0.44 | -$0.42 | -$0.43 |
| Q1 2025 | 3 | -$0.48 | -$0.43 | -$0.46 |
| Q2 2025 | 2 | -$0.65 | -$0.24 | -$0.48 |
| Q3 2025 | 2 | -$0.68 | -$0.24 | -$0.50 |
| Q4 2025 | 2 | -$0.67 | -$0.24 | -$0.49 |
Orchestra BioMed Holdings, Inc. Earnings Date And Information
Orchestra BioMed Holdings, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.41 earnings per share for the quarter, topping analysts' consensus estimates of $-0.44 by $0.03. The company had revenue of 987,000 for the quarter and had revenue of 2.76 M for the year. Orchestra BioMed Holdings, Inc. has generated $-1 earnings per share over the last year ($-1.48 diluted earnings per share) and currently has a price-to-earnings ratio of -3.55. Orchestra BioMed Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Orchestra BioMed Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.44 | -$0.41 | 0.03 | $703,250 | $987,000 |
| 08/12/2024 | Q2 2024 | -$0.41 | -$0.45 | -0.04 | $850,000 | $778,000 |
| 05/13/2024 | Q1 2024 | -$0.40 | -$0.38 | 0.02 | $620,000 | |
| 03/27/2024 | Q4 2023 | -$0.36 | $262,000 | |||
| 09/29/2023 | Q3 2023 | -$0.38 | $895,000 | $419,000 | ||
| 06/30/2023 | Q2 2023 | -$0.35 | $706,000 | $915,000 | ||
| 03/31/2023 | Q1 2023 | -$0.40 | $1.16 M | |||
| 12/30/2022 | Q4 2022 | -$0.08 | $1.10 M | |||
| 09/29/2022 | Q3 2022 | -$0.05 | $1.16 M | |||
| 06/30/2022 | Q2 2022 | -$0.25 | $401,000 | |||
| 03/31/2022 | Q1 2022 | -$0.18 | $866,000 | |||
| 12/30/2021 | Q4 2021 | -$0.00 | $-2,453,000 | |||
| 09/29/2021 | Q3 2021 | -$0.00 | $1.33 M | |||
| 06/29/2021 | Q2 2021 | -$0.00 | $-978,000 | |||
| 03/30/2021 | Q1 2021 | -$0.01 | $1.32 M |
Orchestra BioMed Holdings, Inc. Earnings: Frequently Asked Questions
-
When is Orchestra BioMed Holdings, Inc.'s earnings date?
Orchestra BioMed Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
-
Did Orchestra BioMed Holdings, Inc. beat their earnings estimates last quarter?
In the previous quarter, Orchestra BioMed Holdings, Inc. (:OBIO) reported $-0.41 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.44 by $0.03.
-
How can I listen to Orchestra BioMed Holdings, Inc.'s earnings conference call?
The conference call for Orchestra BioMed Holdings, Inc.'s latest earnings report can be listened to online.
-
How can I read Orchestra BioMed Holdings, Inc.'s conference call transcript?
The conference call transcript for Orchestra BioMed Holdings, Inc.'s latest earnings report can be read online.
-
How much revenue does Orchestra BioMed Holdings, Inc. generate each year?
Orchestra BioMed Holdings, Inc. (:OBIO) has a recorded annual revenue of $2.76 M.
-
How much profit does Orchestra BioMed Holdings, Inc. generate each year?
Orchestra BioMed Holdings, Inc. (:OBIO) has a recorded net income of $2.76 M. Orchestra BioMed Holdings, Inc. has generated $-1.48 earnings per share over the last four quarters.
-
What is Orchestra BioMed Holdings, Inc.'s price-to-earnings ratio?
Orchestra BioMed Holdings, Inc. (:OBIO) has a price-to-earnings ratio of -3.55 and price/earnings-to-growth ratio is 1.86.
